Mesothelioma News

Workers in the United States are not alone in having been negligently exposed to asbestos and falling victim to malignant mesothelioma. Mesothelioma is a global problem, and though America has a reputation for being overly litigious, courts around the world are starting to follow the same path of ordering asbestos companies to pay significant damage

Read More

It is well known that exposure to asbestos causes malignant mesothelioma, asbestosis, and asbestos-related lung cancer. But the deadly material is also responsible for a host of other illnesses, and the EPA’s failure to address both these illnesses and many possible sources of occupational exposure to asbestos is being roundly criticized by its own internal

Read More

It is an unfortunate truth that in the United States and around the world, patients with malignant mesothelioma do not all receive the same level of care. There have been multiple studies documenting the differences and their causes. Some have to do with patients’ age or proximity to state-of-the-art cancer centers. Some have to do

Read More

Patients with malignant mesothelioma suffer innumerable discomforts and adverse effects from both the disease itself and the treatments physicians use to prolong their lives.  Among the most painful of these is neuropathy.  Now researchers from Georgia Tech believe that they’ve arrived at a better understanding of what causes neuropathy, and hope that it will yield an effective

Read More

For more than two years, researchers from the renowned Memorial Sloan Kettering Cancer Center in New York have been studying whether the cancer drug Tazemotostat could inhibit the growth of malignant mesothelioma tumors. At the 2020 ASCO Annual Meeting, they presented data showing that it successfully inactivated the effect of the BAP1 gene mutation and

Read More

Patients with malignant pleural mesothelioma go through a rigorous staging and assessment protocol once their cancer has been diagnosed. The goal is to determine how advanced their cancer is, what their overall health status is and where the tumors are so that the best possible treatment plan can be put in place. One of the

Read More

For years, manufacturers of automobiles and other pieces of equipment requiring replacement parts have denied their responsibility for malignant mesothelioma caused by asbestos in replacement parts for their equipment. They have pointed to the parts manufacturers and tried to wash their hands of responsibility despite the fact that their equipment required those parts to continue

Read More

There’s little question that Navy veteran Herbert H. Mullinex’s malignant mesothelioma comes from exposure to asbestos during his service. He worked on several ships doing shipbuilding and repair. In suing John Crane, Inc., he did so under both federal and maritime law. Though the company has not argued that their product was not responsible, they

Read More

This year’s American Society of Clinical Oncology’s meeting had to be held virtually in light of the global pandemic, but that has in no way interfered with the revelations of remarkable progress in the treatment of malignant pleural mesothelioma.  Among the presentations was news that Italian researchers have significantly improved survival among mesothelioma patients by treating

Read More

Mesothelioma advocates are criticizing EPA decisions as the agency announces another delay in its evaluation of asbestos and its potential for harm. Blaming the challenges created by the global pandemic, EPA chief Andrew Wheeler informed the Senate Environment and Public Works Committee that it would not be able to meet the statutory deadline of June

Read More

A study analyzing characteristics of patients with thoracic cancers like malignant mesothelioma who developed COVID-19 revealed that patients who had received chemotherapy within three months of their diagnosis with the virus had a significantly increased risk of death. The information was presented ahead of the 2020 American Society of Clinical Oncology Virtual Scientific Program, and

Read More

In the hierarchy of treatments used for malignant mesothelioma, radiation therapy has frequently been ranked the lowest: though it can help to provide symptom relief, it has not generally been credited for extended survival or progression free survival. Now a study out of Turkey has introduced statistics that show the use of innovative targeted therapies

Read More

Though people diagnosed with malignant pleural mesothelioma are told at the outset that their condition is both incurable and fatal, that does nothing to stop them from pinning their hopes on innovative medical treatments. Some of those hopes may be fulfilled, as a recent test of a genetically modified virus has proven capable of infecting

Read More

The results are in from a phase II study that tested a combination of standard chemotherapy with a new immunotherapy drug on patients diagnosed with malignant mesothelioma, and the results have been described as “remarkable.” The immunotherapy drug is durvalumab (brand name Infinzi) and it was developed by Medimmune/AstraZeneca. The results will be presented at

Read More

If you have a known exposure to asbestos, whether from the workplace, exposure to a family member who worked with the substance, or some other source, you have long been aware of your risk for malignant mesothelioma, asbestosis, and other asbestos-related diseases. As if those fears were not stressful enough, those same individuals are now

Read More

While multi-million-dollar mesothelioma lawsuits against Johnson & Johnson’s Baby Powder have been capturing headlines, litigation against the company’s talc provider Imerys led the smaller organization to file for bankruptcy last year. This week they announced that they will be selling their North American operations and using the assets to settle more than 14,000 lawsuits against

Read More

In the face of thousands of lawsuits accusing their product of causing malignant mesothelioma and ovarian cancer, Johnson & Johnson has announced that they will no longer sell their talc-based baby powder product in the United States or Canada. The product has long been one of the world’s most recognizable and trusted consumer products.

Read More

Malignant mesothelioma is an asbestos-related disease that is traditionally (and appropriately) associated with occupational settings. Most victims are those who have been exposed to the carcinogen in factories, in high-heat settings like boiler rooms, and while working on construction sites doing insulation work, working with asbestos concrete, and ceiling and floor tile installation or removal.

Read More

For researchers investigating malignant mesothelioma, any progress — no matter how incremental — is to be celebrated. The disease has proven remarkably resistant to treatment, so when scientists identify a way to slow the rare form of cancer’s spread it is notable. Such is the case of a recent discovery by Italian researchers that is detailed

Read More

Malignant mesothelioma is one of the most challenging types of cancer to treat. This is partially due to the disease not being diagnosed until it is in an advanced stage, and partially due to its extreme resistance to chemotherapy. That resistance has been linked to a variety of genetic mutations including a mutation in the

Read More